Education
About Us
Working with TipRanks
Follow Us
Bluebird bio Inc (BLUE)
NASDAQ:BLUE
BLUE Stock Chart & Stats
Day’s Range― - ―
52-Week Range$3.20 - $28.60
Previous CloseN/A
Volume68.97K
Average Volume (3M)N/A
Market Cap
$48.67M
Enterprise Value$156.73M
Total Cash (Recent Filing)$78.74M
Total Debt (Recent Filing)$115.46M
Price to Earnings (P/E)―
Beta1.01
Next Earnings
Aug 12, 2025EPS Estimate
-2.52Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-2.98
Shares Outstanding55,331,000
10 Day Avg. VolumeN/A
30 Day Avg. VolumeN/A
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market Cap3.22
Enterprise Value/Revenue1.51
Enterprise Value/Gross Profit5.56
Enterprise Value/Ebitda-1.18
Forecast
1Y Price Target
$8.00Price Target Upside60.97% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Bulls Say, Bears Say
Bulls Say
Earnings PotentialThe company's portfolio is expected to reach over $600 million in annual sales, triggering a potential cash value right.
Price Target IncreaseThe price target increased significantly to $40 from $2 based on a sum-of-the-parts probability-adjusted discount cash flows.
PrivatizationThe announced privatization of the company is expected to be completed within the first half of 2025.
Bears Say
Conflict Of InterestThere is a potential conflict of interest as the firm may have business dealings with the company covered in the report.
Downgrade In RatingThe company has been moved to a Neutral rating from Underweight, indicating less confidence in outperforming the market.
Sales EstimatesSales estimates for Lyfgenia are reduced due to slower-than-expected uptake in sickle-cell disease.
Bluebird Bio News
BLUE FAQ
What was Bluebird bio Inc’s price range in the past 12 months?
Bluebird bio Inc lowest stock price was $3.20 and its highest was $28.60 in the past 12 months.
What is Bluebird bio Inc’s market cap?
Bluebird bio Inc’s market cap is $48.67M.
When is Bluebird bio Inc’s upcoming earnings report date?
Bluebird bio Inc’s upcoming earnings report date is Aug 12, 2025 which is 4 days ago.
How were Bluebird bio Inc’s earnings last quarter?
Currently, no data Available
Is Bluebird bio Inc overvalued?
According to Wall Street analysts Bluebird bio Inc’s price is currently Undervalued.
Does Bluebird bio Inc pay dividends?
Bluebird bio Inc does not currently pay dividends.
What is Bluebird bio Inc’s EPS estimate?
Bluebird bio Inc’s EPS estimate is -2.52.
How many shares outstanding does Bluebird bio Inc have?
Bluebird bio Inc has 55,331,000 shares outstanding.
What happened to Bluebird bio Inc’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bluebird bio Inc?
Among the largest hedge funds holding Bluebird bio Inc’s share is Graham Capital Management, L.P.. It holds Bluebird bio Inc’s shares valued at 0.
Bluebird Bio Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$8.00 (60.97% Upside)
$8.00 (60.97% Upside)
Blogger Sentiment
Bullish
BLUE Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Decreased
By 66.5K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $7.8K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 0.1%
Last 30 Days ▼ 2.9%
Last 30 Days ▼ 2.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Fundamentals
Return on Equity
-546.55%
Trailing 12-Months
Asset Growth
-53.13%
Trailing 12-Months
Company Description
Bluebird bio Inc
Bluebird Bio, Inc. (BLUE) is a biotechnology company specializing in the development of gene therapies for severe genetic diseases and cancer. The company focuses on developing therapies that address the underlying genetic causes of these conditions, primarily through the use of lentiviral-based gene therapies. Bluebird Bio's core products are designed to treat conditions such as beta-thalassemia, sickle cell disease, and cerebral adrenoleukodystrophy.
Bluebird Bio (BLUE) Earnings & Revenues
Currently, no data available
Please return soon. This page is being updated.
BLUE Stock 12 Month Forecast
Average Price Target
$8.00
▲(60.97% Upside)
Ownership Overview
9.50% Insiders
2.29% Mutual Funds
13.80% Other Institutional Investors
97.71% Public Companies and Individual Investors